{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:49:50Z","timestamp":1791236990610,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-512","type":"journal-article","created":{"date-parts":[[2014,8,10]],"date-time":"2014-08-10T07:00:50Z","timestamp":1407654050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting"],"prefix":"10.1186","volume":"7","author":[{"given":"Wassihun","family":"Wedajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bedru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teklu","family":"Kiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfamariam","family":"Mebrahtu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Yamuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"\u00c4ngeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Werngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Onyebujoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kifle","family":"Dagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,10]]},"reference":[{"key":"3036_CR1","volume-title":"Disease Control Priorities in Developing Countries","author":"AR Measham","year":"2006","unstructured":"Measham AR, Alleyne G, Mills A, Musgrove P, Claeson M, Jamison DT, Evans DB, Breman JG, Jha P: Disease Control Priorities in Developing Countries. 2006, Washington, DC: World Bank and Oxford University Press"},{"key":"3036_CR2","volume-title":"Multidrug and Extensively Drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response","author":"WH Organization","year":"2010","unstructured":"Organization WH: Multidrug and Extensively Drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response. 2010, Geneva: World Health Organization"},{"key":"3036_CR3","volume-title":"Anti-tuberculosis Drug Resistance in the World, Fourth Global report: The WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance","author":"WH Organization","year":"2008","unstructured":"Organization WH: Anti-tuberculosis Drug Resistance in the World, Fourth Global report: The WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2008, Geneva, Switzerland: World Health Organization"},{"key":"3036_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.05.00111304","volume":"25","author":"S Kim","year":"2005","unstructured":"Kim S: Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005, 25: 564-569.","journal-title":"Eur Respir J"},{"key":"3036_CR5","first-page":"21","volume":"41","author":"G Canetti","year":"1969","unstructured":"Canetti G, Fox W, Khomenko A, Mahler H, Menon N, Mitchison D, Rist N, \u0160melev N: Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969, 41: 21-43.","journal-title":"Bull World Health Organ"},{"key":"3036_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1469-0691.2003.00695.x","volume":"9","author":"D Garcia de Viedma","year":"2003","unstructured":"Garcia de Viedma D: Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin Microbiol Infect. 2003, 9: 349-359.","journal-title":"Clin Microbiol Infect"},{"key":"3036_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1574-695X.2009.00555.x","volume":"56","author":"JC Palomino","year":"2009","unstructured":"Palomino JC: Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol. 2009, 56: 103-111.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3036_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jac\/34.3.313","volume":"34","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Young D: Molecular genetics of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 1994, 34: 313-319.","journal-title":"J Antimicrob Chemother"},{"key":"3036_CR9","volume-title":"Policy Statement","author":"World Health Organisation (WHO)","year":"2011","unstructured":"World Health Organisation (WHO): Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF System. Policy Statement. 2011"},{"key":"3036_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/jac\/dkp262","volume":"64","author":"T Sch\u00f6n","year":"2009","unstructured":"Sch\u00f6n T, Jur\u00e9en P, Giske CG, Chryssanthou E, Stureg\u00e5rd E, Werngren J, Kahlmeter G, Hoffner SE, \u00c4ngeby KA: Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother. 2009, 64: 786-793.","journal-title":"J Antimicrob Chemother"},{"key":"3036_CR11","volume-title":"Global Tuberculosis Control: WHO Report","author":"World Health Organisation (WHO)","year":"2010","unstructured":"World Health Organisation (WHO): Global Tuberculosis Control: WHO Report. 2010, Geneva, Switzerland: Global Tuberculosis Programme, World Health Organization"},{"key":"3036_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","volume":"44","author":"S R\u00fcsch-Gerdes","year":"2006","unstructured":"R\u00fcsch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S: Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol. 2006, 44: 688-692.","journal-title":"J Clin Microbiol"},{"key":"3036_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/JCM.44.1.20-28.2006","volume":"44","author":"C Piersimoni","year":"2006","unstructured":"Piersimoni C, Olivieri A, Benacchio L, Scarparo C: Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006, 44: 20-28.","journal-title":"J Clin Microbiol"},{"key":"3036_CR14","first-page":"1449","volume":"12","author":"C Rodrigues","year":"2008","unstructured":"Rodrigues C, Jani J, Shenai S, Thakkar P, Siddiqi S, Mehta A: Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 system. Int J Tubercul Lung Dis. 2008, 12: 1449-1455.","journal-title":"Int J Tubercul Lung Dis"},{"key":"3036_CR15","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1128\/JCM.00244-07","volume":"45","author":"B van Klingeren","year":"2007","unstructured":"van Klingeren B, Dessens-Kroon M, van der Laan T, Kremer K, van Soolingen D: Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol. 2007, 45: 2662-2668.","journal-title":"J Clin Microbiol"},{"key":"3036_CR16","first-page":"304","volume-title":"Manual of Clinical Microbiology","author":"GD Roberts","year":"1991","unstructured":"Roberts GD, Koneman E, Kim YK, Hauser W, Isenberg H: Mycobacterium. Manual of Clinical Microbiology. Edited by: Balow A. 1991, Washington D. C: ASM press, 304-339."},{"key":"3036_CR17","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1128\/JCM.40.7.2339-2345.2002","volume":"40","author":"LM Parsons","year":"2002","unstructured":"Parsons LM, Brosch R, Cole ST, Somosk\u00f6vi \u00c1, Loder A, Bretzel G, Van Soolingen D, Hale YM, Salfinger M: Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol. 2002, 40: 2339-2345.","journal-title":"J Clin Microbiol"},{"key":"3036_CR18","volume-title":"Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Anti-tuberculosis Drugs","author":"World Health Organisation (WHO)","year":"2008","unstructured":"World Health Organisation (WHO): Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Anti-tuberculosis Drugs. 2008"},{"key":"3036_CR19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1128\/JCM.00240-10","volume":"48","author":"P Jur\u00e9en","year":"2010","unstructured":"Jur\u00e9en P, \u00c4ngeby K, Stureg\u00e5rd E, Chryssanthou E, Giske C, Werngren J, Nordvall M, Johansson A, Kahlmeter G, Hoffner S: Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections. J Clin Microbiol. 2010, 48: 1853-1858.","journal-title":"J Clin Microbiol"},{"key":"3036_CR20","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1128\/JCM.00521-07","volume":"45","author":"D Hillemann","year":"2007","unstructured":"Hillemann D, R\u00fcsch-Gerdes S, Richter E: Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007, 45: 2635-2640.","journal-title":"J Clin Microbiol"},{"key":"3036_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jac\/dkq091","volume":"65","author":"KA \u00c4ngeby","year":"2010","unstructured":"\u00c4ngeby KA, Jureen P, Giske C, Chryssanthou E, Stureg\u00e5rd E, Nordvall M, Johansson A, Werngren J, Kahlmeter G, Hoffner S: Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. J Antimicrob Chemother. 2010, 65: 946-952.","journal-title":"J Antimicrob Chemother"},{"key":"3036_CR22","first-page":"564","volume":"3","author":"L Heifets","year":"1999","unstructured":"Heifets L, Cangelosi G: Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tubercul Lung Dis. 1999, 3: 564-581.","journal-title":"Int J Tubercul Lung Dis"},{"key":"3036_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S1473-3099(10)70165-1","volume":"10","author":"J Minion","year":"2010","unstructured":"Minion J, Leung E, Menzies D, Pai M: Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10: 688-698.","journal-title":"Lancet Infect Dis"},{"key":"3036_CR24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1183\/09031936.00059812","volume":"41","author":"SP Fitzwater","year":"2013","unstructured":"Fitzwater SP, Sechler GA, Jave O, Coronel J, Mendoza A, Gilman RH, Friedland JS, Moore DA: Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. Eur Respir J. 2013, 41: 1163-1171.","journal-title":"Eur Respir J"},{"key":"3036_CR25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1186\/1471-2334-5-62","volume":"5","author":"M Morgan","year":"2005","unstructured":"Morgan M, Kalantri S, Flores L, Pai M: A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005, 5: 1471-2334.","journal-title":"BMC Infect Dis"},{"key":"3036_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1164\/rccm.200709-1436OC","volume":"177","author":"M Barnard","year":"2008","unstructured":"Barnard M, Albert H, Coetzee G, O\u2019Brien R, Bosman ME: Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008, 177: 787-792.","journal-title":"Am J Respir Crit Care Med"},{"key":"3036_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/1756-0500-5-462","volume":"5","author":"D Abate","year":"2012","unstructured":"Abate D, Taye B, Abseno M, Biadgilign S: Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia. BMC Res Notes. 2012, 5: 462-474.","journal-title":"BMC Res Notes"},{"key":"3036_CR28","first-page":"367","volume":"46","author":"D Asmamaw","year":"2008","unstructured":"Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A: Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia. Ethiop Med J. 2008, 46: 367-374.","journal-title":"Ethiop Med J"},{"key":"3036_CR29","first-page":"203","volume":"48","author":"M Mekonen","year":"2010","unstructured":"Mekonen M, Abate E, Aseffa A, Anagaw B, Elias D, Hailu E, Idh J, Moges F, Wolde-Amanuel Y, Asrat D: Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia. Ethiop Med J. 2010, 48: 203-210.","journal-title":"Ethiop Med J"},{"key":"3036_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.5588\/ijtld.11.0522","volume":"16","author":"B Tessema","year":"2012","unstructured":"Tessema B, Beer J, Emmrich F, Sack U, Rodloff A: First-and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tubercul Lung Dis. 2012, 16: 805-811.","journal-title":"Int J Tubercul Lung Dis"},{"key":"3036_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1600-0463.2011.02861.x","volume":"120","author":"SA Yimer","year":"2012","unstructured":"Yimer SA, Agonafir M, Derese Y, Sany Y, Bjune GA, Holm\u2012Hansen C: Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia. Apmis. 2012, 120: 503-509.","journal-title":"Apmis"},{"key":"3036_CR32","first-page":"1259","volume":"14","author":"M Agonafir","year":"2010","unstructured":"Agonafir M, Lemma E, Wolde-Meskel D, Goshu S, Santhanam A, Girmachew F, Demissie D, Getahun M, Gebeyehu M, Van Soolingen D: Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tubercul Lung Dis. 2010, 14: 1259-1265.","journal-title":"Int J Tubercul Lung Dis"},{"key":"3036_CR33","first-page":"1355","volume":"13","author":"H Schaaf","year":"2009","unstructured":"Schaaf H, Victor T, Venter A, Brittle W, Jordaan A, Hesseling A, Marais B, Van Helden P, Donald P: Ethionamide cross-and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tubercul Lung Dis. 2009, 13: 1355-1359.","journal-title":"Int J Tubercul Lung Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:20:16Z","timestamp":1630560016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3036"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-512","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,10]]},"assertion":[{"value":"31 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"512"}}